Free Trial

Talis Biomedical Q1 2023 Earnings Report

Talis Biomedical logo
$1.56 -0.19 (-10.63%)
As of 03:00 PM Eastern

Talis Biomedical EPS Results

Actual EPS
-$9.90
Consensus EPS
-$11.10
Beat/Miss
Beat by +$1.20
One Year Ago EPS
N/A

Talis Biomedical Revenue Results

Actual Revenue
$1.22 million
Expected Revenue
$0.10 million
Beat/Miss
Beat by +$1.12 million
YoY Revenue Growth
N/A

Talis Biomedical Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Remove Ads

Talis Biomedical Earnings Headlines

Talis Biomedical Corp Ordinary Shares
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
See More Talis Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Talis Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Talis Biomedical and other key companies, straight to your email.

About Talis Biomedical

Talis Biomedical (NASDAQ:TLIS) operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

View Talis Biomedical Profile

More Earnings Resources from MarketBeat